Spyre Therapeutics
SYRE
SYRE
29 hedge funds and large institutions have $43.9M invested in Spyre Therapeutics in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
82% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 17
Holders
29
Holding in Top 10
1
Calls
$33K
Puts
–
Top Buyers
| 1 | +$7.54M | |
| 2 | +$3.67M | |
| 3 | +$1.19M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$1.03M |
| 5 |
PA
Perceptive Advisors
New York
|
+$994K |
Top Sellers
| 1 | -$1.85M | |
| 2 | -$1.54M | |
| 3 | -$739K | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$647K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$534K |